Back

Ever Supreme Bio’s CAR001 receives FDA orphan drug designation

Verifying
  • Ever Supreme Bio Technology received FDA orphan drug designation for CAR001.
  • CAR001 is an independently developed allogeneic off-the-shelf CAR-T drug candidate.
  • The designation marks another milestone in Ever Supreme Bio Technology’s cell therapy pipeline.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.